Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-003196
Filing Date
2009-03-26
Accepted
2009-03-26 07:45:35
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2191875z10-k.htm 10-K 1139852
2 EX-10.27 a2191875zex-10_27.htm EX-10.27 620021
3 EXHIBIT 23.1 a2191875zex-23_1.htm EX-23.1 3531
4 EXHIBIT 23.2 a2191875zex-23_2.htm EX-23.2 3846
5 EXHIBIT 31.1 a2191875zex-31_1.htm EX-31.1 8033
6 EXHIBIT 31.2 a2191875zex-31_2.htm EX-31.2 8080
7 EXHIBIT 32.1 a2191875zex-32_1.htm EX-32.1 5235
8 G496443.JPG g496443.jpg GRAPHIC 49118
  Complete submission text file 0001047469-09-003196.txt   1857668
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33277 | Film No.: 09705348
SIC: 2834 Pharmaceutical Preparations